Rizwana Parveen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rizwana Parveen has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Nidhi Bharal Agarwal
Department of Translational and Clinical Research, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India
2 shared publications - Mohd Ashif Khan
Department of Translational and Clinical Research, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India
1 shared publication - Pinki Mishra
Department of Translational and Clinical Research, School of Chemical and Life Sciences, Jamia Hamdard
1 shared publication - Prabhat Varshney
Centre for Translational and Clinical Research, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India
1 shared publication - Ram Bajpai
School of Medicine, Keele University , Keele
1 shared publication - Sunil Kohli
Department of Medicine, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India
1 shared publication
Latest Publications
- Open Access
- 13 June 2022
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 55 (4) , 321-333
Vitamin D Deficiency and Comorbidities as Risk Factors of COVID-19 Infection: A Systematic Review and Meta-analysis
Objectives: Extensive evidence links low vitamin D status and comorbidities with coronavirus disease 2019 (COVID-19) outcomes, but the results of published studies are contradictory. Therefore, we investigated the association of lower levels of vitamin D and comorbidities with the risk of COVID-19 infection.Methods: We searched MEDLINE (via PubMed), Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov for articles published until August 20, 2021. Sixteen eligible studies were identified (386 631 patients, of whom 181 114 were male). We included observational cohort and case-control studies that evaluated serum levels of vitamin D in COVID-19-positive and COVID-19-negative patients. Mean differences (MDs) with 95% confidence intervals (CIs) were calculated.Results: Significantly lower vitamin D levels were found in COVID-19-positive patients (MD, -1.70; 95% CI, -2.74 to -0.66; p=0.001), but with variation by study design (case-control: -4.04; 95% CI, -5.98 to -2.10; p<0.001; cohort: -0.39; 95% CI, -1.62 to 0.84; p=0.538). This relationship was more prominent in female patients (MD, -2.18; 95% CI, -4.08 to -0.28; p=0.024) than in male patients (MD, -1.74; 95% CI, -3.79 to 0.31; p=0.096). Male patients showed higher odds of having low vitamin D levels (odds ratio [OR], 2.09; 95% CI, 1.38 to 3.17; p<0.001) than female patients (OR, 1.17; 95% CI, 0.74 to 1.86; p=0.477). Comorbidities showed inconsistent, but generally non-significant, associations with COVID-19 infection.Conclusions: Low serum vitamin-D levels were significantly associated with the risk of COVID-19 infection. This relationship was stronger in female than in male COVID-19 patients. Limited evidence was found for the relationships between comorbidities and COVID-19 infection, warranting large population-based studies to clarify these associations.
- 13 June 2022
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 55 (4) , 321-333
Open AccessVitamin D Deficiency and Comorbidities as Risk Factors of COVID-19 Infection: A Systematic Review and Meta-analysis
Objectives: Extensive evidence links low vitamin D status and comorbidities with coronavirus disease 2019 (COVID-19) outcomes, but the results of published studies are contradictory. Therefore, we investigated the association of lower levels of vitamin D and comorbidities with the risk of COVID-19 infection.Methods: We searched MEDLINE (via PubMed), Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov for articles published until August 20, 2021. Sixteen eligible studies were identified (386 631 patients, of whom 181 114 were male). We included observational cohort and case-control studies that evaluated serum levels of vitamin D in COVID-19-positive and COVID-19-negative patients. Mean differences (MDs) with 95% confidence intervals (CIs) were calculated.Results: Significantly lower vitamin D levels were found in COVID-19-positive patients (MD, -1.70; 95% CI, -2.74 to -0.66; p=0.001), but with variation by study design (case-control: -4.04; 95% CI, -5.98 to -2.10; p<0.001; cohort: -0.39; 95% CI, -1.62 to 0.84; p=0.538). This relationship was more prominent in female patients (MD, -2.18; 95% CI, -4.08 to -0.28; p=0.024) than in male patients (MD, -1.74; 95% CI, -3.79 to 0.31; p=0.096). Male patients showed higher odds of having low vitamin D levels (odds ratio [OR], 2.09; 95% CI, 1.38 to 3.17; p<0.001) than female patients (OR, 1.17; 95% CI, 0.74 to 1.86; p=0.477). Comorbidities showed inconsistent, but generally non-significant, associations with COVID-19 infection.Conclusions: Low serum vitamin-D levels were significantly associated with the risk of COVID-19 infection. This relationship was stronger in female than in male COVID-19 patients. Limited evidence was found for the relationships between comorbidities and COVID-19 infection, warranting large population-based studies to clarify these associations.
- Open Access
- 1 May 2020
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (5) , 255-261
Increased serum interleukin-9 and interleukin-1β are associated with depression in type 2 diabetes patients
Inflammation has been ascertained as an integral mechanism in patients with both diabetes and depression. Certain clinical studies have reported that raised serum markers of inflammation, particularly IL-6, are associated with the onset of T2DM12. Different cohort studies indicate the involvement of activated innate immunity in patients with T2DM11. Depression has been found to be associated with impaired immune system and increased susceptibility to various diseases. An increase in plasma cytokines and acute phase protein concentration has been reported in the blood of depressed patients. Cytokines affect multiple CNS functions that are dysregulated during depression. Moreover, external administration of IL into the CNS has been found to induce immune function and produce stress-like effect on behavior13. Studies have highlighted higher levels of IL-1β and IL-6 in patients with T2DM and depression14. IL-9, which is a Th2-related cytokine, has been reported to be over-expressed in the post mortem brains of depressed people15. It is a pleiotropic cytokine whose elevated levels have been linked to allergic lung inflammation16.
- 1 May 2020
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 78 (5) , 255-261
Open AccessIncreased serum interleukin-9 and interleukin-1β are associated with depression in type 2 diabetes patients
Inflammation has been ascertained as an integral mechanism in patients with both diabetes and depression. Certain clinical studies have reported that raised serum markers of inflammation, particularly IL-6, are associated with the onset of T2DM12. Different cohort studies indicate the involvement of activated innate immunity in patients with T2DM11. Depression has been found to be associated with impaired immune system and increased susceptibility to various diseases. An increase in plasma cytokines and acute phase protein concentration has been reported in the blood of depressed patients. Cytokines affect multiple CNS functions that are dysregulated during depression. Moreover, external administration of IL into the CNS has been found to induce immune function and produce stress-like effect on behavior13. Studies have highlighted higher levels of IL-1β and IL-6 in patients with T2DM and depression14. IL-9, which is a Th2-related cytokine, has been reported to be over-expressed in the post mortem brains of depressed people15. It is a pleiotropic cytokine whose elevated levels have been linked to allergic lung inflammation16.